Study guide
11.3 Ephedrine and Pseudoephedrine Sales Restrictions: Federal & Alabama Law
Alabama MPJE Pharmacy Jurisprudence Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Board of Pharmacy Governance & Pharmacist Licensure
1.1 Alabama State Board of Pharmacy: Structure, Powers, Rulemaking & the 2026 Nine-Member Board 1.2 Pharmacist Licensure Requirements: Examination, Education, Background Check & Reciprocity 1.3 Pharmacy Interns, Externs & Preceptor Requirements: 1,500 Practical Hours & Supervision Standards
2 Chapter 2: Pharmacy Support Personnel, Ratios & Professional Standards
2.1 Pharmacy Technicians: Registration, Qualifications, Scope of Duties & Tiered Ratios 2.2 License Renewal Cycles, Continuing Education (CE) & Inactive Status 2.3 Disciplinary Grounds, Sanctions, Administrative Hearings & Impaired Pharmacist Rehabilitation
3 Chapter 3: Prescribing Authority, Practitioner Scopes & Corresponding Responsibility
3.1 Prescriptive Authority by Profession: Independent vs. Limited Scopes 3.2 Mid-Level Prescribing: PAs, CRNPs, CNMs, QACSC & Limited Purpose Schedule II Permits (LPSP) 3.3 Corresponding Responsibility, Legitimate Medical Purpose & Red Flags for Controlled Substance Diversion
4 Chapter 4: Opioids, Controlled Substance Clinical Safeguards & Naloxone Access
4.1 Opioid Prescribing Standards: ALBME Risk & Abuse Mitigation, MME Thresholds & Pain-Management Registration 4.2 Overdose Prevention: Statewide Naloxone Standing Order, Co-Prescribing & Pharmacist Dispensing Protocols 4.3 Alabama Prescription Drug Monitoring Program (PDMP): Dispenser Daily Reporting & Prescriber Query Mandates
5 Chapter 5: Clinical Services, Immunizations & Collaborative Practice
5.1 Pharmacist Immunization Authority, Protocols & Training Standards 5.2 Collaborative Drug Therapy Management (CDTM) & Collaborative Practice Agreements 5.3 Patient Counseling & Prospective Drug Utilization Review (DUR) Standards
6 Chapter 6: Prescription Validity, Electronic Prescribing & Security Standards
6.1 Prescription Form Validity: Written, Oral/Telephone & Facsimile Requirements 6.2 Electronic Prescribing & Electronic Prescriptions for Controlled Substances (EPCS) 6.3 Alabama Generic Drug Substitution: Two-Signature Line Law & Therapeutic Equivalence
7 Chapter 7: Prescription Processing, Labeling, Packaging & Emergency Dispensing
7.1 Prescription Labeling Standards & Expiration / Beyond-Use Dating 7.2 Federal Packaging Mandates: Poison Prevention Packaging Act (PPPA) & Child-Resistant Containers 7.3 Emergency Prescription Dispensing: 72-Hour Supply Rule & Disaster Provisions 7.4 Partial Filling of Prescriptions: Non-Controlled, Schedule II & Schedules III–V
8 Chapter 8: Prescription Transfers, Delivery & Remote Pharmacy Services
8.1 Prescription Transfer Rules: Non-Controlled vs. Controlled Substances 8.2 Prescription Delivery, Mail-Order Distribution & Out-of-State Permits 8.3 Patient Records, Confidentiality & Permitted Health Information Disclosures 8.4 Remote Pharmacist Work, Off-Site Order Entry & Off-Site Vaccine Order Processing
9 Chapter 9: Pharmacy Facility Standards, Security & Operational Supervision
9.1 Pharmacy Facility Permits: Application, Inspection, Renewal & Change of Ownership 9.2 Prescription Department Technical Equipment, References & Storage Standards 9.3 Pharmacy Security, Keys & Controlled Access Standards 9.4 Supervising Pharmacist Responsibilities & Temporary Absence
10 Chapter 10: Controlled Substances: Scheduling, Ordering, Inventory & Recordkeeping
10.1 Controlled Substance Scheduling: Federal Framework & Alabama State Variations 10.2 Controlled Substance Ordering & Procurement: DEA Form 222, CSOS & Invoicing 10.3 Controlled Substance Inventory Standards: Alabama Annual Inventory on January 15 10.4 Controlled Substance Records, 2-Year Retention & Filing Systems 10.5 Drug Distribution & Supply-Chain Security: DSCSA, Wholesale Distribution & Alabama Permits
11 Chapter 11: Controlled Substance Diversion Control, Disposal & Precursor Regulation
11.1 Theft and Loss of Controlled Substances: DEA Form 106 & Alabama Board Reporting Requirements 11.2 Controlled Substance Disposal, Destruction & Reverse Distribution 11.3 Ephedrine and Pseudoephedrine Sales Restrictions: Federal & Alabama Law 11.4 Non-Prescription Products: OTC Labeling, Repackaging, Exempt Narcotics & Restricted Distribution
12 Chapter 12: Compounding Standards, Institutional Practice & Medication Safety
12.1 Non-Sterile Compounding Standards: USP <795>, Beyond-Use Dating & Alabama Standards 12.2 Sterile Compounding & Hazardous Drug Handling: USP <797>, USP <800> & Facility Requirements 12.3 Institutional Pharmacy Practice: Absence of Pharmacist, Night Cabinets, Stat Cabinets & Emergency Kits 12.4 Medication Safety, Drug Recalls (Classes I-III), Adulteration, Misbranding & Return/Reuse Prohibitions
11.3 Ephedrine and Pseudoephedrine Sales Restrictions: Federal & Alabama Law
Key Takeaways Explain This Topic AI
Under the federal Combat Methamphetamine Epidemic Act of 2005 (CMEA), ephedrine, pseudoephedrine, and phenylpropanolamine are classified as Scheduled Listed Chemical Products (SLCPs), requiring behind-the-counter storage, employee training, and annual DEA self-certification.
Alabama law (Code of Alabama 1975 § 20-2-190) is stricter than federal law, capping non-prescription retail purchases of ephedrine or pseudoephedrine base at 7.5 grams per 30-day period (compared to the federal 9.0-gram monthly limit).
Both federal and Alabama statutes enforce an identical daily ceiling of 3.6 grams of ephedrine or pseudoephedrine base per purchaser per calendar day, regardless of the number of retail transactions.
Under Alabama law, purchasers must be at least eighteen (18) years of age and present a valid, unexpired government-issued photographic identification displaying their name, address, and date of birth.
Alabama pharmacies must transmit transaction data in real time to the National Precursor Log Exchange (NPLEx) and must refuse the sale if a stop-sale alert is generated, with an override permitted only under a reasonable fear of imminent bodily harm.
Last updated: September 2026
11.3 Ephedrine and Pseudoephedrine Sales Restrictions: Federal & Alabama Law
Note
Dual Statutory Framework & State Preemption Dynamics : The illicit synthesis of methamphetamine in clandestine laboratories fueled a nationwide public health crisis in the early 2000s, driven primarily by the easy diversion of non-prescription cold and allergy remedies containing ephedrine and pseudoephedrine. Congress enacted Title VII of the USA PATRIOT Improvement and Reauthorization Act of 2005, known as the Combat Methamphetamine Epidemic Act of 2005 (CMEA) (codified in 21 U.S.C. § 830 and 21 C.F.R. Part 1314), creating federal baseline restrictions on "Scheduled Listed Chemical Products" (SLCPs). However, the State of Alabama responded by passing even more restrictive precursor statutes codified in the Alabama Uniform Controlled Substances Act (Code of Alabama 1975 § 20-2-190 et seq.) . On the Alabama MPJE, where federal and state standards diverge, the more stringent state law strictly controls .
Every pharmacy practitioner in Alabama must understand that dispensing non-prescription ephedrine or pseudoephedrine products is not treated as a standard over-the-counter transaction. It is an intensely regulated sale requiring mandatory government credential verification, real-time electronic law-enforcement database querying, strict quantity ceilings, and statutory criminal exposure.
Federal Baseline: The Combat Methamphetamine Epidemic Act (CMEA)
The CMEA established nationwide baseline controls governing retail sales of Scheduled Listed Chemical Products (SLCPs), which include any non-prescription product containing ephedrine, pseudoephedrine (PSE), or phenylpropanolamine (PPA) .
1. Storage & Physical Placement Mandates
Under 21 C.F.R. § 1314.25, SLCPs must be stored behind the pharmacy service counter or in a locked display cabinet located in an area of the facility to which the general public does not have direct access. Customers cannot self-select precursor products from open retail floor shelving.
2. Retailer Annual Self-Certification
All regulated sellers (community pharmacies and retail establishments) must submit an annual self-certification to the DEA Diversion Control Division via the DEA web portal:
The permit holder must certify that all employees who interact with customers and handle SLCP sales have completed mandatory, documented training on CMEA legal restrictions.
Documented employee training logs and certificates must be maintained and readily retrievable for DEA and ALBOP inspections.
Sellers cannot lawfully sell any SLCP without an active, renewed DEA self-certification certificate posted or filed on site.
Quantitative Sales Ceilings: Federal vs. Alabama Law
The numerical limits governing precursor sales represent the single most heavily tested distinction in Alabama pharmacy jurisprudence. Candidates must memorize the divergence between federal and Alabama 30-day ceilings. +---------------------------------------------------------------------------------------------------------+
- | Precursor Quantitative Limits: Federal vs. Alabama Law |
- +---------------------------------------------------------------------------------------------------------+
- | Statutory Metric | Federal CMEA Baseline (21 U.S.C. § 830) | Alabama Law (Ala. Code § 20-2-190) |
- +-------------------------------+-----------------------------------------+-------------------------------+
- | Daily Sales Ceiling | 3.6 grams base per purchaser / day | 3.6 grams base per purchaser / day |
- +-------------------------------+-----------------------------------------+-------------------------------+
| 30-Day Period Sales Ceiling | 9.0 grams base per purchaser / 30 days | 7.5 GRAMS BASE per 30 days (STRICTER!)|
- +-------------------------------+-----------------------------------------+-------------------------------+
- | Mail-Order 30-Day Limit | 7.5 grams base per 30 days | Prohibited for retail OTC in AL|
- +-------------------------------+-----------------------------------------+-------------------------------+
- | Minimum Age for Purchase | No federal minimum age specified | EIGHTEEN (18) YEARS OF AGE |
- +-------------------------------+-----------------------------------------+-------------------------------+
- | Electronic Logbook Tracking | Logbook required (electronic or paper) | MANDATORY NPLEx REAL-TIME LOG |
- +-------------------------------+-----------------------------------------+-------------------------------+
[!CRITICAL] The Alabama 7.5-Gram Rule : While federal law allows up to 9.0 grams of pseudoephedrine base at retail per 30-day period, Alabama law (Ala. Code § 20-2-190(b)) strictly caps retail sales at 7.5 GRAMS of base per 30-day period . Answering "9.0 grams" on an Alabama MPJE question regarding retail non-prescription purchase limits is a fatal error. Alabama is significantly more restrictive than federal law.
Chemical Mathematics: Salt Weight vs. Free Base Weight
Statutory limits apply to the weight of pure chemical base , not the gross salt weight printed prominently on the package. The two most common pharmaceutical salts are pseudoephedrine hydrochloride (HCl) and pseudoephedrine sulfate:
Pseudoephedrine HCl : Contains approximately 82.2% pseudoephedrine base (Gross weight × 0.822 = base weight).
Pseudoephedrine Sulfate : Contains approximately 77.5% pseudoephedrine base (Gross weight × 0.775 = base weight). +---------------------------------------------------------------------------------------------------------+
- | Precursor Calculation Reference Matrix |
- +---------------------------------------------------------------------------------------------------------+
- | Commercial Formulation | Gross Salt Content per Tab | Base Equivalent per Tab | Max Tabs / 3.6 g Day |
+-------------------------------+----------------------------+-------------------------+--------------------------+
- | Pseudoephedrine HCl 30 mg | 30.0 mg | ~24.65 mg (0.02465 g) | 146 Tablets (3.59 g base)|
- | Pseudoephedrine HCl 60 mg | 60.0 mg | ~49.30 mg (0.04930 g) | 73 Tablets (3.59 g base) |
- | Pseudoephedrine HCl 120 mg | 120.0 mg | ~98.60 mg (0.09860 g) | 36 Tablets (3.55 g base) |
- | Pseudoephedrine Sulfate 120 mg| 120.0 mg | ~93.00 mg (0.09300 g) | 38 Tablets (3.53 g base) |
+-------------------------------+----------------------------+-------------------------+--------------------------+
Alabama Age & Identification Mandates
Under Code of Alabama 1975 § 20-2-190(b), retailers cannot sell, distribute, or deliver any ephedrine or pseudoephedrine product to any person unless specific identity and age criteria are met:
Eighteen (18) Year Age Minimum : The purchaser must be at least eighteen (18) years of age . Although federal CMEA statutes do not establish a minimum age threshold, Alabama state law strictly bars anyone under 18 from purchasing precursor medications. Selling pseudoephedrine to a 17-year-old minor—even with parental notes or student ID—constitutes a criminal misdemeanor under Alabama law.
Valid Government Photo Identification : The purchaser must display an unexpired, valid government-issued photographic identification card issued by a state or federal agency. Acceptable forms of identification include:
- An active state driver's license;
- A state-issued non-driver photographic identification card;
- An official United States Passport;
A United States Military identification card.
Student identification cards, private employer badges, library cards, and expired driver's licenses are legally unacceptable.
Mandatory Real-Time Electronic Tracking: The NPLEx System
Alabama does not permit the use of paper bound logbooks for routine precursor transactions. Under Code of Alabama 1975 § 20-2-190(c), every pharmacy and retail seller must utilize the National Precursor Log Exchange (NPLEx) . +---------------------------------------------------------------------------------------------------------+
- | Alabama NPLEx Stop-Sale Transaction Flow |
- +---------------------------------------------------------------------------------------------------------+
- | 1. Customer Presents Product & Photo ID at Pharmacy Counter (Must be >= 18 years old) |
- | 2. Pharmacy Enters Transaction into NPLEx: Name, address, DOB, ID type/number, product, grams base |
- | 3. Real-Time Inter-Pharmacy Database Query across Alabama and participating nationwide retailers |
- | 4. System Evaluation: |
- | ├─► If Cumulative Purchase <= 3.6 g/day AND <= 7.5 g/30-days: |
- | │ • NPLEx returns "TRANSACTION APPROVED" |
- | │ • Customer signs electronic signature pad; sale is completed |
- | │ |
- | └─► If Purchase Exceeds 3.6 g/day OR 7.5 g/30-days: |
- | • NPLEx generates real-time red "STOP-SALE" ALERT |
- | • Retailer MUST HALT THE TRANSACTION IMMEDIATELY |
- | • Override is STRICTLY PROHIBITED (Except under reasonable fear of imminent bodily harm) |
- +---------------------------------------------------------------------------------------------------------+
- Mandatory NPLEx Data Entry Elements
Before completing any non-prescription transfer of ephedrine or pseudoephedrine, the pharmacy employee must enter the following data points into the real-time NPLEx interface:
- Full legal name and physical residential address of the purchaser;
- Date of birth of the purchaser;
- Type of government photo ID presented and unique ID number;
- Date and precise time of the transaction;
- Name of the chemical precursor and commercial product description;
- Total quantity sold in grams of pure chemical base;
Signature of the purchaser (captured via electronic signature pad).
The Mandatory Stop-Sale Alert & Refusal Mandate
NPLEx immediately cross-references the purchaser's identification against all historical precursor sales conducted across all participating retail pharmacies in Alabama and nationwide during the preceding 30 days:
If the transaction would cause the purchaser to exceed 3.6 grams in a single day or 7.5 grams in a 30-day rolling window , NPLEx generates an automated stop-sale alert .
Upon receipt of a stop-sale alert, the pharmacy is legally prohibited from completing the transaction .
The employee cannot override the system simply because the customer presents a doctor's note, claims severe symptoms, or offers a cash premium.
The "Fear of Imminent Bodily Harm" Statutory Override Exception
Under Code of Alabama 1975 § 20-2-190(e), there is exactly one statutory exception that legally justifies overriding an NPLEx stop-sale alert:
Warning
The Imminent Physical Threat Defense : A pharmacy employee may override an NPLEx stop-sale notification only if the employee reasonably believes that refusing the sale will result in imminent bodily harm or physical injury to the employee, pharmacy staff, or other persons on the premises (e.g., an armed robbery, violent physical threat, or brandished weapon). The override protects retail personnel from violent assault. Following any such emergency override, the pharmacy must immediately report the encounter and perpetrator details to local law enforcement.
System Outage Contingency Protocol
If the pharmacy suffers a catastrophic electrical disruption or telecommunications outage that severs connectivity to NPLEx:
The pharmacy may maintain a mechanical paper bound logbook capturing every statutory data element (name, address, DOB, ID number, product, grams base, date, time, and physical signature).
All manual transactions logged during the outage must be entered into the electronic NPLEx system within seventy-two (72) hours following the restoration of telecommunications connectivity.
Criminal Penalties & Precursor Offenses
Alabama enforces severe criminal penalties against both unlawful purchasers and non-compliant retailers:
Unlawful Purchase Violations : Purchasing or attempting to purchase ephedrine or pseudoephedrine in excess of 3.6 grams per day or 7.5 grams per 30-day period is a Class A misdemeanor for a first conviction, and escalates to a Class C felony for repeat offenses.
Possession with Intent to Manufacture : Possessing precursor chemicals with the intent to manufacture methamphetamine is a Class C felony under Alabama law, punishable by up to 10 years imprisonment.
Smurfing & Conspiracy : Recruiting multiple third-party individuals to purchase small quantities of pseudoephedrine under legal limits across multiple pharmacies ("smurfing") to aggregate bulk precursors for clandestine labs constitutes criminal conspiracy under Code of Alabama 1975 § 20-2-190.